Physician profile
Sheldon Edwards
NPI 1124557707
$1,098.21
in general payments reported to CMS, 2019-2025
17 companies · $896 in 2025
The $896 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $202 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $169.15 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $168.64 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $158.62 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $140.08 | 2024-2025 | |
| Astellas Pharma US INC | $73.78 | 2024-2025 | Veozah |
| Lilly USA, LLC | $66.88 | 2024-2025 | Zepbound, Mounjaro |
| Amgen INC. | $42.88 | 2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $38.57 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $37.37 | 2024-2025 | Eliquis, Camzyos |
| Dexcom, INC. | $34.74 | 2024-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $32.43 | 2025 | Zoryve |
| Exact Sciences Corporation | $32.30 | 2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $23.02 | 2025 | Korlym |
| Boston Scientific Corporation | $22.67 | 2025 | Bodyguardian |
| Abbott Laboratories | $21.57 | 2025 | Freestyle Libre 3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $19.09 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.42 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.